Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Structural heart disease

Cardiovascular MR Perfusion Imaging: Good Initial Alternative in Stable Chronic Angina

In the initial management of patients with stable chronic angina, a non-invasive strategy with cardiovascular MR perfusion...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

Closing off the Appendage While Performing Cardiac Surgery Results in a Reduction in Risk of Embolic Stroke

Closing off the left appendage as an add-on procedure while performing other cardiac surgery in patients with...
solaci -
Learn More
Mitral valve

Percutaneous Repair of Paravalvular Leaks After TAVR: The Challenge of Identifying Eligible Subjects

Courtesy of Dr. Carlos Fava. This study enrolled 72 patients who underwent transcatheter aortic valve replacement with an Edwards Sapiens valve,...
solaci -
Learn More
Structural heart disease

MANTA Closure Device for large-bore arteriotomy closure: Is It Safe?

 Courtesy of Dr. Agustín Vecchia.  The number of transcatheter aortic valve replacements (TAVR) and the placement of aortic endoprosthesis and...
solaci -
Learn More
Structural heart disease

TAVI Frailty Indices: We Should Start Using Them

Courtesy of Dr. Carlos Fava. Frailty should be taken into account when deciding transcatheter aortic valve implantation (TAVI)....
solaci -
Learn More
Structural heart disease

Pacing with a 0.035” Guidewire, an Old Technique Coming Back to Simplify TAVR

This study seeks to prove the safety and efficacy of rapid left ventricular pacing through a 0.035”...
solaci -
Learn More
Mitral valve

MitraClip: Impact of Sinus Rhythm and Heart Rate

Courtesy of Dr. Carlos Fava. Atrial fibrillation (AF) and fast heart rate (>70 lpm) have been shown to...
solaci -
Learn More
Structural heart disease

Cerebral Protection in TAVR: Does It Improve Cognitive Function?

Neurological complications during transcatheter aortic valve replacement (TAVR) may be reduced with cerebral protection devices; this study...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy